These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 686252)

  • 1. Oxolinic acid for the treatment of chronic gastrointestinal Shigella carriers.
    Ribner BS; Freimer EH
    Am J Trop Med Hyg; 1978 Jul; 27(4):840-2. PubMed ID: 686252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic value of Gramurin (oxolinic acid) in Shigella infections and Shigella-negative dysentery syndrome.
    Münnich D; Lehel F
    Ther Hung; 1990; 38(1):41-3. PubMed ID: 2345905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxolonic acid (Gramurin) in the treatment of shigella infections.
    Münnich D
    Ther Hung; 1979; 27(1):33-6. PubMed ID: 494139
    [No Abstract]   [Full Text] [Related]  

  • 4. Further data referring to oxolinic acid (Gramurin) treatment of shigellosis, salmonellosis and urinary tract infections.
    Münnich D; Zarándy B; Békési I
    Ther Hung; 1984; 32(4):149-54. PubMed ID: 6571200
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimicrobial resistance of Shigellae isolated in Michigan.
    Gordon RC; Thompson TR; Carlson W; Dyke JW; Stevens LI
    JAMA; 1975 Mar; 231(11):1159-61. PubMed ID: 1089819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Further data on the association of bacteriophage with antibiotic therapy for the purpose of sterilizing carriers of dysentery bacilli].
    Zilişteanu C; Mintzer-Morgenstern L; Ionesco H; Ionesco-Dorohoi T
    Arch Roum Pathol Exp Microbiol; 1969 Dec; 28(4):1073-80. PubMed ID: 5398933
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse effect of lomotil therapy in shigellosis.
    DuPont HL; Hornick RB
    JAMA; 1973 Dec; 226(13):1525-8. PubMed ID: 4587313
    [No Abstract]   [Full Text] [Related]  

  • 8. Lactulose therapy in Shigella carrier state and acute dysentery.
    Levine MM; Hornick RB
    Antimicrob Agents Chemother; 1975 Nov; 8(5):581-4. PubMed ID: 2098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Shigella-carrier state.
    Levine MM; DuPont HL; Khodabandelou M; Hornick RB
    N Engl J Med; 1973 May; 288(22):1169-71. PubMed ID: 4573124
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current aspects of sterilization of carriers of Shigella].
    Procopan V; Struşievici B; Gavrilă I; Suciu O; Ardeleanu R
    Microbiol Parazitol Epidemiol (Bucur); 1969; 14(1):57-64. PubMed ID: 4888809
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical approach to infectious diarrheas.
    DuPont HL; Hornick RB
    Medicine (Baltimore); 1973 Jul; 52(4):265-70. PubMed ID: 4578991
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic effect of hetacillin in dysentery patients and carriers].
    Yamagami S; Akao M
    Jpn J Antibiot; 1968 Jun; 21(3):115-7. PubMed ID: 4881249
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of repeated antibiotic or chemotherapeutic treatments on Shigella carrier states].
    Brauner E; Ioan E; Turcu T; Mihalache D; Hurmuzache T; Feller H; Cercel I; Iosefsohn J; Cohn E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1977; 22(1):17-21. PubMed ID: 141081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim-sulfamethoxazole in the treatment of gastrointestinal infections, including enteric fever and typhoid carriers.
    Geddes AM
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):35-6. PubMed ID: 805647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methods of treating the dysenteric bacterial carrier state].
    Feklisova LV; Kurnosova NA; D'iakova EI
    Pediatriia; 1974; 53(5):68-70. PubMed ID: 4603684
    [No Abstract]   [Full Text] [Related]  

  • 16. Clearance of Shigella flexneri carriers in a zoologic collection of primates.
    Banish LD; Sims R; Bush M; Sack D; Montali RJ
    J Am Vet Med Assoc; 1993 Jul; 203(1):133-6. PubMed ID: 8407447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of lincomycin on bacillary dysentery (with reference to the results in cases of prolonged bacterial discharge and carriers)].
    Nakazawa S; Oka S; Sato H; Yamagishi M; Saito M
    Nihon Densenbyo Gakkai Zasshi; 1967 Feb; 40(11):409-16. PubMed ID: 4963105
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of bacillary dysentery with Hetacillin (BL-P 804). Preliminary report].
    Totani T; Yamada Y; Amano F
    J Antibiot B; 1967 Apr; 20(2):108-10. PubMed ID: 4861541
    [No Abstract]   [Full Text] [Related]  

  • 19. [Assessment of therapeutic measures used in the treatment of protracted, chronic dysentery accompanied by long-term carrier state].
    Speranskiĭ NP
    Pediatriia; 1971 Nov; 50(11):21-5. PubMed ID: 4112265
    [No Abstract]   [Full Text] [Related]  

  • 20. A chronic carrier of trimethoprim-sulphamethoxazole-resistant Shigella flexneri serotype 1.
    Gebre-Yohannes A; Dekker PA
    Ethiop Med J; 1981 Apr; 19(2):53-7. PubMed ID: 7026229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.